

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | €0.74 | €295.83 €266.24 Free shipping | |
| 180 pills | €0.77 | €154.63 €139.17 | |
| 120 pills | €0.79 | €104.20 €93.78 | |
| 90 pills | €0.83 | €84.03 €75.63 | |
| 60 pills | €0.86 | €57.13 €51.42 | |
| 30 pills | €0.92 | €30.24 €27.22 | |
| 10 pills | €1.06 | €11.75 €10.57 | |
| 360 pills | €1.15 | €460.56 €414.50 Free shipping | |
| 180 pills | €1.20 | €238.68 €214.81 Free shipping | |
| 120 pills | €1.23 | €163.03 €146.73 | |
| 90 pills | €1.29 | €129.42 €116.47 | |
| 60 pills | €1.35 | €89.07 €80.17 | |
| 30 pills | €1.44 | €48.73 €43.86 | |
| 10 pills | €1.65 | €18.47 €16.63 |
Disclaimer: This information is for general patient guidance and is not a substitute for professional medical advice. Always consult a healthcare professional before starting or stopping any medicine.
Prevacid is a proton pump inhibitor (PPI) containing the active ingredient lansoprazole; it reduces stomach acid production to treat conditions related to excess acid.
Prevacid belongs to the proton pump inhibitor class, a group of medicines that act on the stomach’s acid-secreting cells to limit acid output. The active ingredient lansoprazole is released in the stomach to inhibit acid production at the source of secretion.
The primary therapeutic purpose is to promote healing of damaged esophageal or stomach tissue caused by acid reflux and to relieve symptoms such as heartburn and indigestion in appropriate patients. The medicine may also be used for other acid-related disorders as determined by a clinician. In Ireland, availability and prescription requirements may vary by product form and local rules.
When used as prescribed, Prevacid aims to reduce daily acid exposure, support healing of ulcers or erosions, and improve comfort from related symptoms. It is essential to follow the exact dosing schedule provided by a clinician or pharmacist and to complete the prescribed course unless advised otherwise.
Prevacid is prescribed to manage conditions driven by excessive gastric acidity that cause persistent discomfort or tissue damage. The information below summarises common indications, but does not replace personalised medical advice.
In adults, the medication is used to control symptoms and to assist healing in acid-related disorders of the upper digestive tract. The aim is to reduce ongoing irritation and allow tissue repair to occur. Some uses depend on concomitant conditions or the presence of ulcers or erosions.
Conditions treated with lansoprazole include those involving reflux of stomach contents into the esophagus, as well as ulcers of the stomach or duodenum. In certain rare cases, it may be employed for other acid-related disorders as guided by a clinician. A comprehensive assessment is required to determine suitability and duration of therapy.
The following conditions may be considered for treatment with Prevacid in appropriate clinical scenarios. The list is not exhaustive and requires professional assessment to confirm suitability:
Prevacid works by inhibiting the proton pumps in the stomach lining, specifically the H+/K+-ATPase enzyme responsible for acid production. This action lowers gastric acidity across the day and night. The reduction in acid helps protect damaged tissue and supports healing processes in the stomach and esophagus.
The pharmacologic effect is sustained over the dosing interval, with maximum suppression typically occurring after chronic dosing rather than immediate use. By diminishing acid exposure, symptoms such as heartburn and regurgitation may lessen over time, while ulcers or erosions have a chance to heal. The medication does not provide immediate relief for all symptoms and may require several days to achieve full effect.
Prevacid acts locally within the stomach and does not prevent the formation of new ulcers in all circumstances; long-term therapy requires ongoing medical supervision to assess effectiveness and safety. If there is confusion about how the drug works, a pharmacist or clinician can explain the mechanism in relation to a specific treatment plan.
Understanding this mechanism can help patients recognise the purpose of ongoing therapy: to reduce acid-related irritation and allow mucosal healing, thereby improving daily comfort and quality of life in appropriate cases.
The medication is usually taken once daily, and timing before a meal is commonly recommended to maximise absorption and effect. The exact dose and duration depend on the condition being treated and the patient’s response, as determined by a clinician. Do not adjust the dose without professional advice.
Prevacid tablets or capsules should be swallowed whole with water; do not crush, chew, or break delayed-release forms unless specifically instructed. For certain formulations intended to dissolve in water or to be opened for administration, follow the product instructions provided by a pharmacist or the patient information leaflet.
It may be taken with or without food, but adherence to a consistent routine is helpful for maintaining stable acid suppression. If a dose is missed, it should be taken as soon as remembered unless the next dose is due; do not double the dose to make up for a missed one. In case of uncertainty, contact a pharmacist for guidance tailored to the product form used.
Special considerations include: discussing the use of antacids with a clinician, understanding that the onset of symptom relief may take several days, and avoiding abrupt stopping without medical advice, especially after longer courses of therapy. The exact dosing schedule should be confirmed with a clinician or pharmacist based on the formulation used in Ireland. For children, elderly patients, or those with liver impairment, dose adjustments may be required and must be guided by a health professional.
Prevacid should not be used by individuals with a known allergy or hypersensitivity to lansoprazole or to any other ingredients in the product. A described hypersensitivity reaction could be serious, and medical attention should be sought if signs occur.
Contraindications include a history of severe liver disease in which drug metabolism is markedly altered, unless specifically advised by a clinician who understands the individual’s condition. If there is a concern about liver function, a clinician should be consulted prior to starting treatment.
If a person has a known severe reaction to any proton pump inhibitor, a clinician will assess alternatives to avoid cross-reactivity. The decision to use Prevacid in such circumstances should be guided by a healthcare professional and supported by the official patient information leaflet for the exact product form used.
In cases where the patient is pregnant or breastfeeding, or where other medicines are being used that could interact, professional guidance is essential to determine safety and appropriateness. If there is any doubt about suitability, seek advice from a pharmacist or physician before starting therapy with lansoprazole.
Long-term use of proton pump inhibitors, including lansoprazole, has been associated with certain risks in some patients. It is important to discuss personal health history with a clinician before initiating therapy. Vitamin and mineral absorption may be affected when gastric acidity is persistently reduced.
Potential nutrient interactions include reduced absorption of calcium, magnesium, iron, and vitamin B12; these factors may influence bone health or anaemia risk with prolonged use. A clinician may recommend monitoring or dietary adjustments if therapy is planned for an extended period.
Serious but uncommon adverse events have been reported in association with PPI therapy. Any new or increasing symptoms such as severe diarrhea, fever, abdominal pain, dark urine, or jaundice should prompt medical evaluation to rule out infection or liver concerns. Seek urgent medical help if chest pain or symptoms resembling a heart attack occur while taking this medicine.
When combined with certain drugs, lansoprazole can alter effectiveness or increase adverse effects. A clinician should review all current medicines, including herbal products and over‑the‑counter preparations, to assess interactions. If new medicines are started while taking Prevacid, a healthcare professional should be informed promptly.
Common side effects may include headache, abdominal discomfort, nausea, diarrhea, vomiting, and flatulence; these typically resolve without the need for treatment modification. If these symptoms persist or worsen, a clinician may adjust the regimen or suggest supportive measures.
Less common effects can include dizziness, dry mouth, and skin reactions such as rash. Sensible observation for unusual symptoms is advised, and reporting to a pharmacist or doctor is encouraged if concerns arise. Some individuals may notice changes in taste or belching after taking the medicine.
Serious adverse events are uncommon but require immediate medical attention. Signs may include severe allergic reactions (swelling of lips or face, difficulty breathing), persistent vomiting, severe stomach pain, or signs of liver injury (yellowing of skin or eyes, dark urine). Any such symptoms warrant urgent assessment by a healthcare professional.
Allergic reactions, skin reactions, and rare gastrointestinal infections like Clostridioides difficile–associated illness have been reported in rare cases with PPI therapy. If there is any concern about a possible allergic reaction, contact a clinician promptly. The information leaflets accompanying the product provide a detailed list of potential side effects and guidance on management.]
The absorption and effectiveness of lansoprazole can be influenced by other medicines or substances that affect stomach acidity or drug metabolism. A clinician should review all medicines, including vitamins, minerals, herbal products, and over‑the‑counter agents, to identify potential interactions.
Notable considerations include potential interactions with certain antiplatelet drugs, antibiotics, and drugs that require an acidic environment for absorption. In some cases, concomitant use with a proton pump inhibitor may modify the effectiveness of other therapies; consulting a healthcare professional is advised before combining treatments.
In addition, long-term suppression of stomach acid may reduce the absorption of nutrients and certain minerals. If multiple medicines are needed, a clinician may suggest timing adjustments to minimise interaction risk, such as staggering doses where appropriate and practical. Patients should always inform a pharmacist or clinician about all current medications and supplements before starting Prevacid.
Food and beverages generally do not necessitate stopping Prevacid, but some formulations may have specific instructions. A clinician can provide guidance tailored to the product form used in Ireland, including whether to take the medicine with meals or on an empty stomach to optimise effect. If uncertain, seek professional advice before making changes to an established regimen.
Pregnancy and breastfeeding require careful consideration of any medication. The potential benefits and risks of lansoprazole therapy should be discussed with an obstetrician or midwife, along with a clinician responsible for the pregnancy’s care. Where possible, the lowest effective dose and shortest duration should be used under medical supervision.
Data on lansoprazole use during pregnancy is not definitive; a clinician will weigh potential benefits against possible risks. If pregnancy occurs or is planned while taking Prevacid, a healthcare professional should be consulted promptly to review the treatment plan.
Breastfeeding while on this medication should be discussed with a clinician because limited information exists about the amount of drug that passes into breast milk. If required, alternative management strategies may be considered, taking into account the infant’s health and the mother’s condition.
In all cases, if pregnancy is a possibility or if there are concerns about breastfeeding, professional guidance should be sought to determine whether continuing Prevacid is appropriate. Check the official leaflets and speak with a pharmacist or doctor for personalised advice based on the specific product and clinical scenario.
The following questions address common concerns about timing, missed doses, interactions, and duration of treatment. Answers are provided with careful language and without fixed dosing details; consult the official patient information leaflet for precise instructions and a clinician for personalised guidance.
Can Prevacid provide immediate relief for heartburn, or does it require several days to work? Lansoprazole typically requires a few days to achieve full effect as acid production adjusts; some symptom relief may occur earlier, but lasting improvement usually develops with continued use. If symptoms persist beyond a reasonable timeframe, a clinician should be contacted.
What should be done if a dose is missed? A dose should be taken as soon as remembered unless the next dose is due soon. Do not double the dose to compensate for a missed one. If unsure, contact a pharmacist for guidance based on the specific product form used.
Is it safe to take Prevacid with antacids? Antacids can be used as needed for immediate relief, but it is often acceptable to take them separately from the PPI by several hours, if advised by a clinician. Always follow professional guidance on timing and combinations.
How long can Prevacid be used? The duration depends on the condition and response to therapy. Long-term use requires regular medical review to assess ongoing need, benefit, and safety, and to monitor for potential nutrient deficiencies or other risks.
What happens if symptoms return after stopping therapy? Rebound acid secretion can occur after stopping a PPI in some individuals. A clinician can advise on gradual tapering, alternative strategies, or restarting treatment if symptoms recur and are clinically significant.
Can Prevacid interact with vitamins or supplements? Some supplements may interfere with absorption or increase side effects. A clinician should be informed about all supplements being taken to assess potential interactions and adjust therapy if needed.
Is it safe to use Prevacid in elderly patients or those with liver disease? In older adults or people with liver impairment, dose adjustments or additional monitoring may be necessary; a clinician will assess risk and plan accordingly. The patient information leaflet provides specific cautions relevant to the formulation used.
Can children use Prevacid? The safety and dosing in children depend on age and weight, and must be guided by a pediatrician or qualified healthcare professional. The product label for pediatric use provides age-appropriate recommendations and monitoring needs.
What should be done if there is a serious side effect or allergic reaction? Seek urgent medical help if signs of a severe reaction occur, such as swelling of the face or throat, difficulty breathing, or widespread rash. Report any persistent or concerning adverse effects to a clinician or pharmacist promptly.
What if there is uncertainty about whether Prevacid is appropriate? If there is any doubt regarding suitability, consult the official product leaflet and seek professional advice from a pharmacist or physician who can evaluate the individual health status and concomitant medications.
Where can additional information be found? The official patient information leaflet supplied with the medicine, together with guidance from a pharmacist or clinician, provides authoritative details. National health service resources or the manufacturer’s guidance may also be consulted for product-specific information relevant in Ireland.
Official patient information leaflets accompany each product form and provide detailed instructions, warnings, and storage information. These leaflets should be consulted for exact dosing, excipient lists, and instructions tailored to the specific product used in Ireland.
Healthcare professionals, including pharmacists and doctors, can offer personalised advice based on the patient’s medical history, current medications, and treatment goals. Pharmacists at the point of sale are available to answer questions about administration, potential interactions, and safety concerns.
For further support, contact the local health service information resources or national guidance on medication safety. In cases of uncertainty or adverse reactions, prompt consultation with a healthcare professional is advised to ensure safe and effective use of Prevacid. If there is any doubt about the information, refer to the official leaflets or consult a clinician for clarification.
In Ireland, adherence to product labeling and regulatory guidance is essential. The information provided here is intended as a general guide and should be supplemented by professional medical advice based on individual circumstances and the specific product form used. Always verify details with a pharmacist or prescriber before making changes to a treatment plan.
14–21 days. Free from €182.27 .
5–9 days. €27.34
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
